BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 32228507)

  • 1. CHD4 mediates proliferation and migration of non-small cell lung cancer via the RhoA/ROCK pathway by regulating PHF5A.
    Xu N; Liu F; Wu S; Ye M; Ge H; Zhang M; Song Y; Tong L; Zhou J; Bai C
    BMC Cancer; 2020 Mar; 20(1):262. PubMed ID: 32228507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [PHF5A Promotes Proliferation and Migration of Non-Small Cell Lung Cancer 
by Regulating of PI3K/AKT Pathway].
    Wang H; Liu F; Bai C; Xu N
    Zhongguo Fei Ai Za Zhi; 2023 Jan; 26(1):10-16. PubMed ID: 36792075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncNORAD interference inhibits tumor growth and lung cancer cell proliferation, invasion and migration by down-regulating CXCR4 to suppress RhoA/ROCK signaling pathway.
    Wu Y; Shen QW; Niu YX; Chen XY; Liu HW; Shen XY
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5446-5455. PubMed ID: 32495879
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Yang Y; Li M; Zhou X; Wang W; Shao Y; Yao J; Wang X
    Ann Clin Lab Sci; 2022 May; 52(3):439-451. PubMed ID: 35777798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of sema4D in vasculogenic mimicry formation in non-small cell lung cancer and the underlying mechanisms.
    Xia Y; Cai XY; Fan JQ; Zhang LL; Ren JH; Li ZY; Zhang RG; Zhu F; Wu G
    Int J Cancer; 2019 May; 144(9):2227-2238. PubMed ID: 30374974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PHD finger protein 5A promoted lung adenocarcinoma progression via alternative splicing.
    Mao S; Li Y; Lu Z; Che Y; Huang J; Lei Y; Wang Y; Liu C; Wang X; Zheng S; Sun N; He J
    Cancer Med; 2019 May; 8(5):2429-2441. PubMed ID: 30932358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA-binding protein KHSRP promotes tumor growth and metastasis in non-small cell lung cancer.
    Yan M; Sun L; Li J; Yu H; Lin H; Yu T; Zhao F; Zhu M; Liu L; Geng Q; Kong H; Pan H; Yao M
    J Exp Clin Cancer Res; 2019 Nov; 38(1):478. PubMed ID: 31775888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B-Myb Mediates Proliferation and Migration of Non-Small-Cell Lung Cancer via Suppressing IGFBP3.
    Fan X; Wang Y; Jiang T; Cai W; Jin Y; Niu Y; Zhu H; Bu Y
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29772705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Desmoglein-2 is overexpressed in non-small cell lung cancer tissues and its knockdown suppresses NSCLC growth by regulation of p27 and CDK2.
    Cai F; Zhu Q; Miao Y; Shen S; Su X; Shi Y
    J Cancer Res Clin Oncol; 2017 Jan; 143(1):59-69. PubMed ID: 27629878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of STIM1 expression inhibits non-small-cell lung cancer cell proliferation
    Ge C; Zeng B; Li R; Li Z; Fu Q; Wang W; Wang Z; Dong S; Lai Z; Wang Y; Xue Y; Guo J; Di T; Song X
    Bioengineered; 2019 Dec; 10(1):425-436. PubMed ID: 31564210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel long non-coding RNA LBX2-AS1 indicates poor prognosis and promotes cell proliferation and metastasis through Notch signaling in non-small cell lung cancer.
    Tang LX; Su SF; Wan Q; He P; Xhang Y; Cheng XM
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7419-7429. PubMed ID: 31539129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blocking Modification of Eukaryotic Initiation 5A2 Antagonizes Cervical Carcinoma via Inhibition of RhoA/ROCK Signal Transduction Pathway.
    Liu X; Chen D; Liu J; Chu Z; Liu D
    Technol Cancer Res Treat; 2017 Oct; 16(5):630-638. PubMed ID: 27609633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell adhesion molecule 4 suppresses cell growth and metastasis by inhibiting the Akt signaling pathway in non-small cell lung cancer.
    Luo F; Zhao Y; Liu J
    Int J Biochem Cell Biol; 2020 Jun; 123():105750. PubMed ID: 32325280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NT5DC2 suppression restrains progression towards metastasis of non-small-cell lung cancer through regulation p53 signaling.
    Jin X; Liu X; Zhang Z; Xu L
    Biochem Biophys Res Commun; 2020 Dec; 533(3):354-361. PubMed ID: 32962856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TIPE3 differentially modulates proliferation and migration of human non-small-cell lung cancer cells via distinct subcellular location.
    Wang G; Guo C; Zhao H; Pan Z; Zhu F; Zhang L; Wang Q
    BMC Cancer; 2018 Mar; 18(1):260. PubMed ID: 29510688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cullin 3 overexpression inhibits lung cancer metastasis and is associated with survival of lung adenocarcinoma.
    Zhou J; Zhang S; Xu Y; Ye W; Li Z; Chen Z; He Z
    Clin Exp Metastasis; 2020 Feb; 37(1):115-124. PubMed ID: 31463796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
    Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
    Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DEK depletion negatively regulates Rho/ROCK/MLC pathway in non-small cell lung cancer.
    Wang J; Sun L; Yang M; Luo W; Gao Y; Liu Z; Qiu X; Wang E
    J Histochem Cytochem; 2013 Jul; 61(7):510-21. PubMed ID: 23571382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA SNHG15 accelerates the progression of non-small cell lung cancer by absorbing miR-211-3p.
    Ma XR; Xu YL; Qian J; Wang Y
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1536-1544. PubMed ID: 30840276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defeating EpCAM(+) liver cancer stem cells by targeting chromatin remodeling enzyme CHD4 in human hepatocellular carcinoma.
    Nio K; Yamashita T; Okada H; Kondo M; Hayashi T; Hara Y; Nomura Y; Zeng SS; Yoshida M; Hayashi T; Sunagozaka H; Oishi N; Honda M; Kaneko S
    J Hepatol; 2015 Nov; 63(5):1164-72. PubMed ID: 26095183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.